Neoadjuvant and perioperative therapy for gastric carcinomas;Neoadjuvante und perioperative therapie des magenkarzinoms

Onkologe

Volumn 14, Issue 4, 2008, Pages 370-380

  Wilke, H ^a   Willich, N ^b   Meyer, H J ^c   Stahl, M ^a  

^a KLINIKEN ESSEN MITTE   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Pathologisches Institut   (Germany)

Author keywords

Adenocarcinomas of the stomach; Perioperative treatment; Postoperative chemoradiation; Preoperative and postoperative chemotherapy; Preoperative chemoradiation

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN; VINBLASTINE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; ENDOSCOPIC ECHOGRAPHY; ESOPHAGEAL ADENOCARCINOMA; HUMAN; LOWER ESOPHAGUS SPHINCTER; MORBIDITY; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; REVIEW; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; SURGICAL MORTALITY;

EID: 44149109604     PISSN: 09478965     EISSN: 14330415     Source Type: Journal    
DOI: 10.1007/s00761-008-1337-x     Document Type: Review

References (63)

1. Roder JD, Böttcher K, Siewert JR et al. (1993) Prognostic factors in gastric carcinoma. Cancer 72: 2089
2. Meyer H-J, Jähne J, Wilke H et al. (1991) Surgical treatment of gastric cancer: Retrospective survey of 1704 operated cases with special reference to total gastrectomy as operation of choice. Semin Surg Oncol 7: 356
3. Siewert JR, Sendler A, Lordick F (2006) Magenkarzinom. In: Siewert JR, Rothmund M, Schumpelick V (Hrsg) Viszeralchirurgie. Springer, Heidelberg, S 4555-4481
4. Hazard L, O'Connor J, Scaife C (2006) Role of radiation therapy in gastric cancer. World J Gastroenterol 12: 1511-1520
5. Rivera F, Vega-Villegas ME, Lopez-Brea MF (2007) Chemotherapy of advanced gastric cancer. Cancer Treat Rev 33: 315-324
6. Roth AD (2003) Curative treatment of gastric cancer: towards a multidisciplinary approach? Crit Rev Oncol Hematol 46: 59-100
7. Hermans J, Bonenkamp JJ, Boon MC et al. (1993) Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials. J Clin Oncol 11: 1441-1447
8. Earle CC, Maroun JA (1999) Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 35: 1059-1064
9. Mari E, Floriani I, Tinazzi A et al. (2000) Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 11: 837-843
10. Panzini I, Gianni L, Fattori PP et al. (2002) Adjuvant chemotherapy in gastric cancer: a review of randomized trials and a comparison with previous meta-analyses. Tumori 88: 21-27
11. Janunger KG, Hafström L, Glimelius B (2002) Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 168: 597-608
12. Nakajima T, Kinoshita T, Nashimoto A et al. (2007) Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Br J Surg 94: 1468-1476
13. Sakuramoto S, Sasako M, Yamaguchi T et al. (2007) Adjuvant chemotherapy for gastric cancer with S1- an oral fluoropyrimidine. N Engl J Med 357: 1810-1820
14. Cunningham D, Chua YJ (2007) East meets West in the treatment of gastric cancer. N Engl J Med 357: 1863-1865
15. Macdonald JS, Smalley SR, Benedetti J et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730
16. Wilke H, Preusser P, Fink U et al. (1989) Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 7: 1318
17. Wilke H, Preusser P, Fink U et al. (1990) New developments in the treatment of gastric carcinoma. Semin Oncol (Suppl 2) 17: 61-70
18. Plukker JT, Mulder NH, Sleijfer DT et al. (1991) Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil. Br J Surg 78: 995
19. Popiela T, Kulig J, Skucinski J et al. (1992) Advances in treatment of seriously advanced gastric cancer using aggressive EAP chemotherapy. In Proceedings of an International Symposium "Gastric Cancer", May 25-26, Cracow, pp 108-116
20. Rosen HR, Scheithauer W, Jakesz R et al. (1995) Epirubicin, etoposide and cisplatin in the treatment of locally advanced, nonresectable gastric carcinoma - results of a multiticentric pilot study. GI Cancer 1: 49-53
21. Gallardo-Rincon D, Onate-Ocana LF, Caldillero-Ruiz G (2000) Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study. Ann Surg Oncol 7: 45-50
22. Leichman L, Silbermann H, Leichman CG et al. (1992) Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: A University of Southern California pilot program. J Clin Oncol 10: 1933-1942
23. Ajani JA, Mayer RJ, Ota DM et al. (1993) Preoperative and postoperative combination chemotherapy for potentially respectable gastric carcinoma. J Natl Cancer Inst 85: 1839-1844
24. Ajani JA, Mansfield PF, Lynch P et al. (1999) Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric cancer. J Clin Oncol 17: 2403-2411
25. Songun I, Keizer HJ, Hermans J et al. (1999) Chemotherapy for operable gastric cancer: results of the Dutch randomized FAMTX trial. The Dutch Gastric Cancer Group. Eur J Cancer 35: 558-562
26. Yonemura Y, Sawa T, Kinoshita K et al. (1993) Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J Surg 17: 256-261
27. Rougier P, Lasser P, Ducreux M et al. (1994) Preoperative chemotherapy of locally advanced gastric cancer. Ann Oncol (Suppl 3) 4: 59-68
28. Facchini G, Tortoriello A, Caponigro F et al. (1995) Neoadjuvant chemotherapy in locally advanced gastric cancer: preliminary results of a phase II trial with a modified FAMTX combination. Oncol Rep 2: 727-730
29. Alexander HR, Grem JL, Hamilton JM et al. (1995) Thymidilate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and esophageal adenocarcinoma. Cancer J 1: 49-54
30. Fink U, Schuhmacher C, Stein HJ et al. (1995) Preoperative chemotherapy for stage III-IV gastric carcinoma: feasibility, response and outcome after complete resection. Br J Surg 82: 1248-1252
31. Kelsen D, Karpeh M, Schwartz G et al. (1996) Neoadjuvant therapy of high risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol 14: 1818-1828
32. Kang YK, Choi DW, Im Y-H et al. (1996) A phase III randomized comparison of neoadjuvant chemotherapy followed by surgery versus surgery for locally advanced stomach cancer. Proc Am Soc Clin Oncol 15: 215
33. Cascinu S, Labianca R, Graziano F et al. (1998) Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br J Cancer 78: 390-393
34. Geh JI, Glynne-Jones R, Kwok QS et al. (2000) Preoperative ECF chemotherapy in gastro-esophageal adenocarcinoma. Clin Oncol (R Coll Radiol) 1283: 182-187
35. Schuhmacher CP, Fink U, Becker K et al. (2001) Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatin. Closing results after 5-years of follow-up. Cancer 91: 918-927
36. Ott K, Sendler A, Becker K et al. (2003) Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study. Gastric Cancer 6: 159-167
37. Tagikushi N, Nunomura M, Koda K et al. (2003) Neoadjuvant chemotherapy with CDDP and 5-fluorouracil for gastric cancer with serosal invasion. Oncol Rep 10: 433-438
38. Cascinu S, Scartozzi M, Labianca R et al. (2004) High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgrastim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br J Cancer 90: 1521-1525
39. Newman E, Potmesil M, Ryan T et al. (2005) Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study. Semin Oncol (Suppl 9) 32: 97-100
40. Persiani R, D'Ugo D, Biondi A et al. (2005) T-downstaging after neoadjuvant chemotherapy in locally advanced gastric carcinoma. Tumori Suppl 4: 88
41. Brenner B, Shah MA, Karpeh MS et al. (2006) A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol 17: 1404-1411
42. Cunningham D, Allum WH, Stenning SP et al. (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 335:
43. Boige V, Pignon J, Saint-Aubert B et al. (2007) Final results of a randomized trial comparing preoperative 5-fluorouracil(F)/cisplatin(P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD-7-FFCD 9703 trial. J Clin Oncol (Suppl 18) 25: 200; Abstrakt 4510
44. Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 359: 1727-1733
45. Wong RK, Tandan V, De Silva S et al. (2007) Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2: CD002102
46. Eberhardt W, Wilke H, Stamatis G et al. (1998) Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol 16: 622-634
47. Stahl M, Stuschke M, Lehmann N et al. (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23: 2310-2317
48. Walsh TN, Noonan N, Hollywood D et al. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335: 462-467
49. Stahl M, Vanhoefer U, Stuschke M et al. (1998) Preoperative sequential chemo- and radiotherapy in locallay advanced carcinomas of the lower oesophagus and gastro-oesophageal junction. Eur J Cancer 34: 668-673
50. Keller SM, Ryan LM, Coia LR et al. (1998) High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: results of a phase II study of the Eastern Cooperative Oncology Group: Cancer 83: 1908-1916
51. Heath EI, Burtness BA, Heitmiller RF et al. (2000) Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 18: 868-876
52. Lowy AM, Feig BW, Janjan N et al. (2001) A pilot study of preoperative chemoradiotherapy for resectable gastric cancer. Ann Surg Oncol 8: 482-483
53. Ajani JA, Komaki R, Putnam JB et al. (2001) A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable adenocarcinoma of the esophagus or gastroesophageal junction. Cancer 92: 279-286
54. Urba SG, Orringer MB, Turrisi A et al. (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19: 305-313
55. Ajani JA, Masnfield PF, Janjan N et al. (2004) Multi-institutional trial of preoperative chemoradiotheraypy in patients with potentially resectable gastric carcinoma. J Clin Oncol 22: 2774-2780
56. Balandraud P, Moutardier V, Giovannini M et al. (2004) Locally advanced adenocarcinomas of the gastric cardia: results of pre-operative chemoradiotherapy. Gastroenterol Clin Biol 28: 651-657
57. Ajani JA, Mansfield PF, Crane CH et al. (2005) Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol 23: 1237-1244
58. Gaca JG, Petersen RP, Peterson BL et al. (2006) Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma. Ann Surg Oncol 13: 340-346
59. Ajani JA, Winter K, Okawara GS et al. (2006) Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality and pathologic response. J Clin Oncol 24: 3953-3958
60. Fujitani K, Ajani JA, Crane CH et al. (2007) Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach and gastroesophageal junction. Ann Surg Oncol 14: 1305-1311
61. Patel PR, Mansfield PF, Crane CH et al. (2007) Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer. Cancer 110: 989-995
62. Wydmanski J, Suwinski R, Poltorak S et al. (2007) The tolerance and efficacy of preoperative chemoradiotherapy followed by gastrectomy in operable gastric cancer: a phase II study. Radiother Oncol 82: 132-136
63. Stahl M, Walz MK, Stuschke M et al. (2007) Preoperative chemotherapy (CTX) versus chemoradiotherapy (CRTX) in locally advanced esophagogastric adenocarcinomas: First results of a randomized phase III trial. J Clin Oncol (Suppl 18) 25: 200; Abstrakt 4511